Cypress, California Clinical Trials

A listing of Cypress, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 52 clinical trials
Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma

To evaluate the safety and tolerability of AMG 910 in adult subjects, and to determine the maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D)

Research Site
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

To assess the effect of pimavanserin on the activities of daily living in subjects with Parkinson's Disease Psychosis

Neurology Center of North Orange County
 (8.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +18 other locations
A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms

Psoriasis is a chronic, systemic, inflammatory disease in which skin cells build up and develop thick, red and white scaly patches on the skin. There is an unmet medical need for effective treatment in pediatric patients and this study is being done to evaluate risankizumab in pediatric participants with moderate …

inflammatory disease
risankizumab
ustekinumab
psoriasis
pediatric
Tien Q Nguyen MD, Inc /ID# 217733
 (8.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +8 other locations
Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression

This is a randomized, double-blind, placebo-controlled, multicenter, Phase 3 study to evaluate if high-dose Octagam 10% therapy can stabilize or improve clinical status in patients with severe Coronavirus disease

throat
FIO2
pao2
coronavirus infection
chest imaging
Octapharma Research Site
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +4 other locations
Effects of Tolperisone on Measures of Drowsiness and Cognitive Function

A Randomized, 4-Period, Crossover Study to characterize the effects of tolperisone 200 mg and 400 mg (supratherapeutic dose) three times a day (TID) over 3 days of dosing on measures of simulated driving performance, cognitive function and drowsiness and compared to placebo and cyclobenzaprine (single-day, residual effect, multiple-day).

CNS Trial
 (8.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Dietary Supplement With and Without a Probiotic

Complex oligosaccharides can alter the gut microbiome by aiding in the growth of certain organisms, and possibly, inhibiting others. The synergy with a probiotic may enhance gastrointestinal colonization.

WCCT Global
 (0.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Phase 3 Efficacy and Safety Study of VVZ-149 Injections for Postoperative Pain Following Bunionectomy

The purpose of this phase 3 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following bunionectomy.

analgesics
bunionectomy
postoperative pain
internal fixation
California Clinical Trial Site
 (5.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

body mass index
tirzepatide
cardiovascular disease
dulaglutide
Diabetes Associates Medical Group
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +650 other locations
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)

antihemophilic factor
factor ix
haemophilia a
bethesda assay
hemophilia
Investigational Site Number 8400010
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +10 other locations
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants  

Primary Objective: To assess the safety profile of each SP0202 formulation and Prevnar 13 in toddlers and infants (after each and any injection). To assess the immune response (serotype specific IgG concentration) of the SP0202 formulations and Prevnar 13 1 month after the administration of one dose in toddlers (Groups …

Investigational Site Number 8400040
 (6.7 away)
  • 0 views
  • 19 Feb, 2024
  • +31 other locations